Both studies published in mid-2011 report that the gene encoding PHGDH is amplified in a significant subset of human tumors and underscore that diversion of glycolytic intermediates into the serine biosynthetic pathway may contribute to tumorigenesis in cancer cells [5, 8, 21, 34]. Here, PHGDH is linked to cancer.